Astrana Health Inc

Latest Results (07.08.2024):

Revenue Growth

Astrana Health Inc. reported a total revenue of $404.4 million for the first quarter of 2024, marking a 20% increase from the $337.2 million reported in the same quarter of the previous year. This growth was primarily driven by solid membership growth across all lines of business and successful management of total cost of care for its members.

Net Income

For the first quarter of 2024, Astrana Health Inc. achieved a net income attributable to the company of $14.8 million, which represents a 13% increase from the $13.1 million reported in the first quarter of 2023. This increase in net income underscores the company's effective cost management and operational efficiency.

Adjusted EBITDA

Astrana Health Inc. reported an adjusted EBITDA of $42.2 million for the first quarter of 2024, reflecting a significant 42% growth compared to the $29.8 million reported in the same period last year. This substantial increase highlights the company's strong financial performance and operational improvements.

Earnings Per Share

The earnings per share (EPS) - diluted for Astrana Health Inc. in the first quarter of 2024 was $0.31, up 11% from $0.28 per share in the first quarter of 2023. This increase in EPS indicates the company's ability to generate higher earnings for its shareholders.

2024 Financial Guidance

Astrana Health Inc. has reiterated its financial guidance for the year ending December 31, 2024. The company expects total revenue to be in the range of $1.65 billion to $1.85 billion, net income attributable to Astrana to be between $61 million and $73 million, adjusted EBITDA to range from $165 million to $185 million, and EPS - diluted to be between $1.28 and $1.52.